Reckitt Benckiser has issued a voluntary recall for Mead Johnson Nutrition brand's baby formula powder. The U.S. Food and Drug Administration (US FDA) said that the health and nutrition firm decided to recall some batches of the said product due to possible bacterial contamination.
As per CNBC, the affected infant formula is being sold in the market as Nutramigen Powder. This infant formula is specially made for babies allergic to cow's milk. The recalled batches were produced in June and distributed to stores in the summer.
Recalled Batches of Nutramigen Powder
Reckitt Benckiser said that so far, it has not received any reports of illnesses or adverse effects related to the recalled Nutramigen Powder. However, the company is urging customers who have bought the milk formula to check the can to see if what they purchased is included in the batches that may have been contaminated.
The company said that the affected products have these batch numbers and their corresponding can sizes: ZL3FHG, 12.6 oz cans, ZL3FMH, 12.6 oz cans, ZL3FPE, 12.6 oz cans, ZL3FQD, 12.6 oz cans, ZL3FRW, 19.8 oz cans, and ZL3FXJ, 12.6 oz cans.
Adverse Effects of Bacterial Infection
Fox Business says the total number of the affected Nutramigen infant powder is about 675,030 cans. The FDA warned on Sunday, Dec. 31, that they may be contaminated with Cronobacter sakazakii.
The National Food Administration further said that the milk formula was made at a production facility in Michigan. The bacteria in the product potentially cause severe infections such as meningitis and sepsis. The FDA listed jaundice, irritability, temperature change, poor feeding, trouble breathing, and unusual movements as the common symptoms of the infection.
Meanwhile, the announcement stressed, "No other U.S. distributed Nutramigen batches or other Reckitt products are impacted."
Photo by: Reckltt Press Release


Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 



